Therapeutic Area Lead, Early Pipeline Scientific Engagement and Communication (Director)

Join Astellas

Do you want to be part of an inclusive team that works to develop innovative therapies for patients? Every day, we are driven to develop and deliver innovative and effective new medicines to patients and physicians. If you want to be part of this exciting work, you belong at Astellas!

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are committed to turning innovative science into medical solutions that bring value and hope to patients and their families.

This position is based in Northbrook, Illinois. Remote work from certain states may be permitted in accordance with Astellas' Responsible Flexibility Guidelines. Candidates interested in remote work are encouraged to apply.

Purpose and Scope :

The Therapeutic Area Lead, Early Scientific Engagement & Communications, will lead the strategic development and execution of scientific communications for Astellas early-stage assets, ensuring alignment with the broader oncology and biopharma portfolio strategy. Reporting to the Head of Early Scientific Engagement and Communications, this role will be embedded within the Quantitative Sciences & Evidence Generation (QSEQ) function, enabling a data-driven, evidence-backed approach that integrates biostatistics, real-world evidence (RWE), epidemiology, and medical writing to shape compelling scientific narratives in oncology.

This role will focus on driving early scientific engagement for oncology assets, from discovery through Proof of Concept (POC), ensuring that emerging data is strategically communicated to internal stakeholders and external audiences. The Director will work closely with Research and Development leaders, leveraging established Scientific Platforms and processes to shape scientific narratives that support value creation. Additionally, this role will provide strategic guidance to Asset Maximization Teams (AMTs) on early data dissemination and collaborate with Corporate Communications to align external messaging, including Investor Relations and corporate announcements.

A key responsibility will be partnering with Scientific Publications to ensure publication strategies are seamlessly integrated within the broader pipeline strategy. The Director will oversee early-phase publication planning, working closely with Subject Matter Experts (SMEs) to optimize content for scientific discourse and potential re-use across multiple channels.

This position will contribute to the expansion of the early scientific engagement function, ensuring scalable, high-impact communication strategies.

Represent early scientific engagement in internal and external discussions, contributing to strategic alignment across the pipeline.

Responsibilities and Accountabilities :

• Lead the development of scientific narratives for early-stage assets and focused-research areas, in partnership with Oncology and Biopharma Research and Development leaders.
• Drive strategic scientific messaging for early pipeline assets from discovery through Proof of Concept (POC), ensuring alignment with corporate and therapeutic area priorities.
• Provide expert guidance to AMTs on early data dissemination, ensuring alignment with development and communication strategies.
• Partner with Corporate Communications to integrate scientific messaging into Investor Relations materials, corporate announcements, and external engagement initiatives.
• Collaborate with Scientific Publications to align on publication strategies, ensuring a cohesive approach across the pipeline.
• Leverage QSEQ's data-driven insights (biostatistics, RWE, epidemiology) to enhance scientific communication strategies.
• Inform and shape publication plans for early-pipeline assets to ensure strategic positioning in scientific discourse.
• Develop and implement publication strategies in collaboration with SMEs, ensuring alignment with evolving clinical data.
• Optimize publication content for re-use across multiple channels, leveraging established scientific platforms.
• Ensure publication strategies support key clinical development and regulatory milestones.
• Develop centralized scientific content for early-pipeline assets to support Medical Education needs.
• Review Medical Information content for scientific accuracy and consistency.
• Guide digital publication enhancements and publication extenders for early-pipeline assets.
• Ensure close collaboration with Scientific Publications while maintaining a distinct focus on early-stage communications.
• Engage with clinical, regulatory, and commercial teams to align scientific insights with broader development strategies.